HK1207122A1 - 糖尿病生物標志物及其應用 - Google Patents

糖尿病生物標志物及其應用

Info

Publication number
HK1207122A1
HK1207122A1 HK15107598.4A HK15107598A HK1207122A1 HK 1207122 A1 HK1207122 A1 HK 1207122A1 HK 15107598 A HK15107598 A HK 15107598A HK 1207122 A1 HK1207122 A1 HK 1207122A1
Authority
HK
Hong Kong
Prior art keywords
usages
biomarkers
diabetes
Prior art date
Application number
HK15107598.4A
Other languages
English (en)
Inventor
李勝輝
馮强
覃俊杰
朱劍鋒
張東亞
揭著業
王俊
汪建
楊煥明
Original Assignee
Bgi Shenzhen
Bgi Shenzhen Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bgi Shenzhen, Bgi Shenzhen Co Ltd filed Critical Bgi Shenzhen
Publication of HK1207122A1 publication Critical patent/HK1207122A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pathology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK15107598.4A 2012-08-01 2015-08-06 糖尿病生物標志物及其應用 HK1207122A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2012079522 2012-08-01
PCT/CN2012/080922 WO2014019271A1 (en) 2012-08-01 2012-09-03 Biomarkers for diabetes and usages thereof

Publications (1)

Publication Number Publication Date
HK1207122A1 true HK1207122A1 (zh) 2016-01-22

Family

ID=50027163

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15107598.4A HK1207122A1 (zh) 2012-08-01 2015-08-06 糖尿病生物標志物及其應用

Country Status (3)

Country Link
US (1) US20150211053A1 (zh)
HK (1) HK1207122A1 (zh)
WO (1) WO2014019271A1 (zh)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
KR101445243B1 (ko) * 2014-03-28 2014-09-29 서울대학교산학협력단 장내 세균의 군집과 기능의 변화를 이용한 대사성 및 염증성 질환의 조기진단
WO2015164555A1 (en) * 2014-04-23 2015-10-29 Cornell University Modulation of fat storage in a subject by altering population levels of christensenellaceae in the gi tract
KR101740893B1 (ko) * 2014-05-20 2017-06-13 주식회사 엠디헬스케어 Ａｋｋｅｒｍａｎｓｉａ ｍｕｃｉｎｉｐｈｉｌａ 균에서 유래하는 세포밖 소포를 유효성분으로 함유하는 대사질환의 치료 또는 예방용 조성물
CN107075563B (zh) * 2014-09-30 2021-05-04 深圳华大基因科技有限公司 用于冠状动脉疾病的生物标记物
WO2016049918A1 (en) * 2014-09-30 2016-04-07 Bgi Shenzhen Co., Limited Biomarkers for coronary artery disease
WO2016049927A1 (en) * 2014-09-30 2016-04-07 Bgi Shenzhen Co., Limited Biomarkers for obesity related diseases
US20170252381A1 (en) * 2014-09-30 2017-09-07 Ruijin Hospital Affiliated To Shanghai Jiao Tong University School Of Medicine Uses of bacteroides in treatment or prevention of obesity and obesity-related diseases
KR101986442B1 (ko) * 2014-09-30 2019-06-05 비지아이 션전 류머티스성 관절염용 바이오마커 및 이의 용도
CN107002023B (zh) * 2014-09-30 2021-04-20 上海交通大学医学院附属瑞金医院 拟杆菌在治疗或预防肥胖相关疾病中的用途
WO2016049937A1 (en) * 2014-09-30 2016-04-07 Bgi Shenzhen Co., Limited Biomarkers for rheumatoid arthritis and usage therof
CN106795479B (zh) * 2014-09-30 2020-12-15 深圳华大基因科技有限公司 类风湿性关节炎的生物标记物及其用途
NO3193901T3 (zh) 2014-12-23 2018-09-01
DK3065748T3 (da) 2014-12-23 2018-01-29 4D Pharma Res Ltd En bacteroides thetaiotaomicron stamme og dens anvendelse til reduktion af inflammation
DK3250676T3 (da) * 2015-01-30 2021-09-06 Bgi Shenzhen Biomarkører for kolorektal cancer-relaterede sygdomme
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
EP3636272A1 (en) 2015-06-15 2020-04-15 4D Pharma Research Limited Compositions comprising bacterial strains
SI3650033T1 (sl) 2015-06-15 2022-05-31 4D Pharma Research Limited Sestavki, ki obsegajo bakterijske seve
TW202222339A (zh) 2015-06-15 2022-06-16 英商4D製藥研究有限公司 包含細菌菌株之組合物
WO2017028312A1 (en) * 2015-08-20 2017-02-23 Bgi Shenzhen Biomarkers for coronary heart disease
CN105296620B (zh) * 2015-10-26 2019-01-15 上海市内分泌代谢病研究所 肠道宏基因组特征作为2型糖尿病阿卡波糖疗效筛选标志
MX2018006240A (es) 2015-11-20 2018-08-01 4D Pharma Res Ltd Composiciones que comprenden cepas bacterianas.
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
SI3313423T1 (sl) 2016-03-04 2019-07-31 4D Pharma Plc Sestavki, ki vsebujejo bakterijske seve Blautia za zdravljenje visceralne preobčutljivosti
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
TW201821093A (zh) 2016-07-13 2018-06-16 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
DK3630136T3 (da) 2017-05-22 2021-05-25 4D Pharma Res Ltd Sammensætninger, der omfatter bakteriestammer
MA41708A (fr) 2017-05-24 2020-04-08 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
LT3638271T (lt) 2017-06-14 2021-01-11 4D Pharma Research Limited Kompozicijos, apimančios bakterines padermes
EP4104843A1 (en) 2017-06-14 2022-12-21 4D Pharma Research Limited Compositions comprising bacterial strains
CN110396537B (zh) * 2018-04-24 2023-06-20 深圳华大生命科学研究院 哮喘生物标志物及其用途
CN111334591A (zh) * 2020-03-13 2020-06-26 西湖大学 一种生物标记物的应用及其检测装置、试剂盒以及检测系统
CN111710364B (zh) * 2020-05-08 2022-02-15 中国科学院深圳先进技术研究院 一种菌群标记物的获取方法、装置、终端及存储介质
CN115125167A (zh) * 2022-06-15 2022-09-30 上海交通大学医学院附属瑞金医院 微生物组合及其用途
CN116230078B (zh) * 2023-05-08 2023-07-07 瑞因迈拓科技(广州)有限公司 一种de novo评估组装基因组污染度的方法
CN117797179B (zh) * 2024-02-23 2024-05-28 广东医科大学 一种2型糖尿病合并非酒精性脂肪肝的小鼠模型构建方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2030623A1 (en) * 2007-08-17 2009-03-04 Nestec S.A. Preventing and/or treating metabolic disorders by modulating the amount of enterobacteria
WO2011140208A2 (en) * 2010-05-04 2011-11-10 University Of Florida Research Foundation, Inc. Methods and compositions for diagnosing and treating autoimmune disorders
GB201021399D0 (en) * 2010-12-16 2011-01-26 Genetic Analysis As Oligonucleotide probe set and methods of microbiota profiling
WO2012142605A1 (en) * 2011-04-15 2012-10-18 Samaritan Health Services Rapid recolonization deployment agent
WO2014019180A1 (zh) * 2012-08-01 2014-02-06 深圳华大基因研究院 确定异常状态生物标记物的方法及系统

Also Published As

Publication number Publication date
WO2014019271A1 (en) 2014-02-06
US20150211053A1 (en) 2015-07-30

Similar Documents

Publication Publication Date Title
HK1207122A1 (zh) 糖尿病生物標志物及其應用
HK1218329A1 (zh) 型糖尿病生物標誌物及其用途
HK1205764A1 (zh) 結核病生物標誌物及其用途
GB201213567D0 (en) Biomarkers
GB201218933D0 (en) An entity
IL234234B (en) 2ang binding molecules
GB201211982D0 (en) Biomarker
ZA201409006B (en) Diabetes biomarkers
EP2861623A4 (en) NEW SPECIFIC CLEC14A ANTIBODY AND USES THEREOF
EP2897614A4 (en) CMPF ACID AS A BIOMARKER FOR DIABETES AND ASSOCIATED METHODS
EP2819749A4 (en) BIOMARKERS ASSOCIATED WITH AUTISM AND USES THEREOF
GB201213163D0 (en) Photopolymerisation processes and novel compounds therefor
EP2828282A4 (en) BIOMARKERS
HK1202899A1 (zh) 糖尿病的生物標誌物
GB201211158D0 (en) Biomarkers and uses thereof
GB201210565D0 (en) Biomarkers
HK1207664A1 (zh) 糖尿病生物標誌物及其應用
PL2626134T3 (pl) Pipeta
EP2889504A4 (en) IRREVERSIBLE MECHANISM
PL2882708T3 (pl) Nowe związki i ich zastosowania
EP2864782A4 (en) BIOMARKERS OF DEMENTIA WITH NEUROFIBRILLARY DEGENERATION
GB201209802D0 (en) Biomarker
EP2804845A4 (en) LITHIUM ION CONDUCTIVE MATERIALS
GB201202944D0 (en) Biomarker
EP2810427A4 (en) CHARACTER SET FOR PRINTING PATTERNS